 |
|
Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Joon Mo Lee
Obstet Gynecol Sci. 2021;64(5):437-443. Published online 2021 Jul 30 DOI: https://doi.org/10.5468/ogs.21093
|
|
Citations to this article as recorded by
 ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer
Aditi Bhatt, Vincent Alcazer, Lisa Frankinet, Naoual Bakrin, Olivier Glehen
Annals of Surgical Oncology.2023; 30(6): 3300. CrossRef Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer
Lisa Frankinet, Aditi Bhatt, Vincent Alcazer, Jean-Marc Classe, Jean-Marc Bereder, Pierre Meeus, Christophe Pomel, Francois Mithieux, Karine Abboud, Romauld Wermert, Vincent Lavoue, Frederic Marchal, Olivier Glehen, Naoual Bakrin
Annals of Surgical Oncology.2023; 30(6): 3287. CrossRef Comment on: hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Shalini Venkatappa, Avir Sarkar
Obstetrics & Gynecology Science.2022; 65(1): 103. CrossRef No obvious advantage of hyperthermic intraperitoneal chemotherapy after interval debulking surgery in the treatment of advanced ovarian cancer: A retrospective study
Mengmeng Lyu, Jin Lu, Yang Shen, Qianqian Chen, Fei Deng, Jinhua Wang
Frontiers in Surgery.2022;[Epub] CrossRef
|